Weight Loss by Plush.MD is a new, comprehensive medical weight loss program featuring highly touted, FDA approved medications, Semaglutide and Tirzepatide.

Semaglutide, the active ingredient in Ozempic and Wegovy, works by reducing appetite and controlling insulin levels, while the active ingredient in Mounjaro and Zepbound, Tirzepatide, is a dual-action injectable medication used to help manage appetite and support weight loss.

Semaglutide is an FDA approved prescription medication that can assist people in achieving their long-term weight loss goals. Semaglutide is the active ingredient in Ozempic and Wegovy. It works by reducing appetite and controlling insulin levels, helping you feel fuller for longer periods of time. When combined with the personalized support and guidance of Susan Tanne, MD and the WEIGHT LOSS by Plush.MD team, you will quickly reach your weight loss goals in a healthy and sustainable way.

Tirzepatide is an injectable medication used to help manage appetite and support weight loss. This innovative therapy aims to improve blood sugar control and weight management by combining the effects of both GIP and GLP-1.

Tirzepatide is the same active ingredient used in Mounjaro and Zepbound. It’s a dual-action GLP-1/GIP that is approved by the FDA for people with obesity.

Both medications are very similar in the way they help with weight loss. The main difference between these medications is the active ingredient. Ozempic and Wegovy use semaglutide, while Mounjaro and Zepbound use tirzepatide. They both work by replacing the GLP1 hormone in our body that tells us that we feel full. Tirzepatide is a dual-action GLP-1 and GIP, meaning it works by activating two hormone receptors that regulate your metabolism, helping you feel full faster and longer. In comparison, semaglutide only activates the GLP-1 receptor.

• Appetite suppression: Semaglutide and Tirzepatide help to reduce appetite, helping you feel fuller for longer periods of time and making it easier to stick to a calorie-restricted diet.
• Slows digestion: Semaglutide and Tirzepatide slow down the rate at which food moves through the digestive system, which can further promote feelings of fullness and reduce the desire to snack between meals.
• Regulates blood sugar control by reducing glucose production in the liver and increasing insulin secretion.

Semaglutide and Tirzepatide are administered via subcutaneous injection and have been proven safe and reliable in clinical studies.

Semaglutide and Tirzepatide injections are used successfully as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 or greater, or 27 or greater when accompanied with at least one weight-related condition such as insulin resistance, hypertension, high cholesterol, heart disease, gout.

Our Plush Meta-Boost B12 Shot is an all-natural lipotropic energy blast and a metabolic kick start all in one quick injection.
This little energy wonder shot does it all – helps detoxify, boosts metabolism, increases energy, and combats stress and fatigue.